文献速递术前评估与围术期医学疼痛医学

微小RNA作为围术期医学的临床生物标志物与治疗工具

MicroRNAs as Clinical Biomarkers and Therapeutic Tools in Perioperative Medicine.
PubMed 文献 · Anesth Analg · 2018-01-01

本文综述了微小RNA(miRNA)的生物学特性及其在人类疾病中的潜在作用,重点介绍了miRNA在围术期医学中的生物标志物研究现状与治疗应用前景,指出miRNA可能为麻醉、重症监护和疼痛医学开辟新视角。

要点

  • miRNA通过结合蛋白编码RNA的3'非翻译区调控基因表达。
  • miRNA是有前景的新型生物标志物和治疗靶点。
  • miRNA正进入围术期医学,可能开拓麻醉、重症和疼痛医学新视角。

核心结论

  • miRNA是围术期医学中极具前景的新型生物标志物和治疗工具。

研究设计与样本

  • 综述,未报告检索范围与样本量。

主要发现

  • miRNA调控几乎所有细胞过程,影响基因表达。
  • miRNA在医学中作为生物标志物和治疗靶点受到关注。
  • miRNA正进入围术期医学领域。

临床怎么用

  • 围术期医学中可关注miRNA作为生物标志物和治疗靶点的潜力。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Over the past decade, evolutionarily conserved, noncoding small RNAs-so-called microRNAs (miRNAs)-have emerged as important regulators of virtually all cellular processes. miRNAs influence gene expression by binding to the 3'-untranslated region of protein-coding RNA, leading to its degradation and translational repression. In medicine, miRNAs have been revealed as novel, highly promising biomarkers and as attractive tools and targets for novel therapeutic approaches. miRNAs are currently entering the field of perioperative medicine, and they may open up new perspectives in anesthesia, critical care, and pain medicine. In this review, we provide an overview of the biology of miRNAs and their potential role in human disease. We highlight current paradigms of miRNA-mediated effects in perioperative medicine and provide a survey of miRNA biomarkers in the field known so far. Finally, we provide a perspective on miRNA-based therapeutic opportunities and perspectives.

来源:Anesth Analg,查看原文。版权归原作者所有。

引用

  1. Kreth S, Hübner M, Hinske LC, et al. MicroRNAs as Clinical Biomarkers and Therapeutic Tools in Perioperative Medicine. Anesth Analg. 2018. PMID: 28922229. doi:10.1213/ANE.0000000000002444

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。